Park JO - Search Results

1

Population Pharmacokinetics of Liposomal Irinotecan in Patients With Cancer.

Adiwijaya BS, Kim J, Lang I, Csõszi T, Cubillo A, Chen JS, Wong M, Park JO, Kim JS, Rau KM, Melichar B, Gallego JB, Fitzgerald J, Belanger B, Molnar I, Ma WW. Adiwijaya BS, et al. Among authors: park jo. Clin Pharmacol Ther. 2017 Dec;102(6):997-1005. doi: 10.1002/cpt.720. Epub 2017 Jun 5. Clin Pharmacol Ther. 2017. PMID: 28445610 Free PMC article.

2

Retrospective comparison of infusional 5-fluorouracil, doxorubicin, and mitomycin-C (modified FAM) combination chemotherapy versus palliative therapy in treatment of advanced gastric cancer.

Park JO, Chung HC, Cho JY, Rha SY, You NC, Kim JH, Noh SH, Kim CB, Min JS, Kim BS, Roh JK. Park JO, et al. Am J Clin Oncol. 1997 Oct;20(5):484-9. doi: 10.1097/00000421-199710000-00010. Am J Clin Oncol. 1997. PMID: 9345333

3

Effect of vinorelbine, ifosfamide, and cisplatin combination chemotherapy in advanced non-small-cell lung cancer.

Ahn JB, Ko WK, Lee JG, Shim KY, Jeung HC, Park JO, Yoo NC, Kim BS, Kim SK, Kim SK, Kim JH. Ahn JB, et al. Among authors: park jo. Am J Clin Oncol. 2000 Dec;23(6):622-8. doi: 10.1097/00000421-200012000-00020. Am J Clin Oncol. 2000. PMID: 11202811 Clinical Trial.

4

Combination chemotherapy with epirubicin, docetaxel and cisplatin (EDP) in metastatic or recurrent, unresectable gastric cancer.

Lee SH, Kang WK, Park J, Kim HY, Kim JH, Lee SI, Park JO, Kim K, Jung CW, Park YS, Im YH, Lee MH, Park K. Lee SH, et al. Among authors: park ys, park jo, park k, park j. Br J Cancer. 2004 Jul 5;91(1):18-22. doi: 10.1038/sj.bjc.6601891. Br J Cancer. 2004. PMID: 15188010 Free PMC article. Clinical Trial.

5

MAP2K1 Mutation in Colorectal Cancer Patients: Therapeutic Challenge Using Patient-Derived Tumor Cell Lines.

Kim JE, Kim KK, Kim SY, Lee J, Park SH, Park JO, Park YS, Lim HY, Kang WK, Kim ST. Kim JE, et al. Among authors: park ys, park sh, park jo. J Cancer. 2017 Jul 20;8(12):2263-2268. doi: 10.7150/jca.19582. eCollection 2017. J Cancer. 2017. PMID: 28819429 Free PMC article.

6

Liposomal irinotecan plus fluorouracil/leucovorin versus FOLFIRINOX as the second-line chemotherapy for patients with metastatic pancreatic cancer: a multicenter retrospective study of the Korean Cancer Study Group (KCSG).

Park HS, Kang B, Chon HJ, Im HS, Lee CK, Kim I, Kang MJ, Hwang JE, Bae WK, Cheon J, Park JO, Hong JY, Kang JH, Kim JH, Lim SH, Kim JW, Kim JW, Yoo C, Choi HJ. Park HS, et al. Among authors: park jo. ESMO Open. 2021 Apr;6(2):100049. doi: 10.1016/j.esmoop.2021.100049. Epub 2021 Feb 9. ESMO Open. 2021. PMID: 33578192 Free PMC article.

7

A comparative study of intravenous granisetron versus intravenous and oral ondansetron in the prevention of nausea and vomiting associated with moderately emetogenic chemotherapy.

Park JO, Rha SY, Yoo NC, Kim JH, Roh JK, Min JS, Kim BS, Chung HC. Park JO, et al. Am J Clin Oncol. 1997 Dec;20(6):569-72. doi: 10.1097/00000421-199712000-00007. Am J Clin Oncol. 1997. PMID: 9391542 Clinical Trial.

8

Physiological and pathological changes of plasma urokinase-type plasminogen activator, plasminogen activator inhibitor-1, and urokinase-type plasminogen activator receptor levels in healthy females and breast cancer patients.

Chung HC, Rha SY, Park JO, Yoo NC, Kim JH, Roh JK, Min JS, Lee KS, Kim BS, Kim JJ. Chung HC, et al. Among authors: park jo. Breast Cancer Res Treat. 1998 May;49(1):41-50. doi: 10.1023/a:1005997421733. Breast Cancer Res Treat. 1998. PMID: 9694610

9

Salvage chemotherapy with irinotecan, 5-fluorouracil and leucovorin for taxane- and cisplatin-refractory, metastatic gastric cancer.

Kim ST, Kang WK, Kang JH, Park KW, Lee J, Lee SH, Park JO, Kim K, Kim WS, Jung CW, Park YS, Im YH, Park K. Kim ST, et al. Among authors: park kw, park ys, park jo, park k. Br J Cancer. 2005 May 23;92(10):1850-4. doi: 10.1038/sj.bjc.6602575. Br J Cancer. 2005. PMID: 15870718 Free PMC article. Clinical Trial.

10

Phase II trial of irinotecan plus oxaliplatin and 5-fluorouracil/leucovorin in patients with untreated metastatic gastric adenocarcinoma.

Lee J, Kang WK, Kwon JM, Oh SY, Lee HR, Kim HJ, Park BB, Lim HY, Han MJ, Park JO, Park YS. Lee J, et al. Among authors: park bb, park ys, park jo. Ann Oncol. 2007 Jan;18(1):88-92. doi: 10.1093/annonc/mdl317. Epub 2006 Sep 13. Ann Oncol. 2007. PMID: 16971670 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

902 results

Search Page

Filters